Literature DB >> 133617

Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.

B K Davis, T Cavallo.   

Abstract

A body of evidence suggests that in membranoproliferative glomerulonephritis (MPGN), complement is activated by the alternate pathway. Therefore, deposition of early components of complement should not be expected in glomeruli. The renal tissues of 16 patients--13 with classic MPGN and 3 with dense deposit disease, a variant of MPGN--were studied by light and electron microscopy and by means of elution and immunofluorescence for the localization of complement (C1q, C4, and C3), immunoglobulins (1gG, IgM, and 1gA), and other serum proteins. Variable amounts of C3, C4 and/or C1q, and IgM were detected in the glomeruli of all patients, whereas IgG and IgA were present, respectively, in 15 of 16 and 6 of 16 patients. Deposits were localized in mesangium and in peripheral capillary loops in a typical lobular distribution. The specificity of each antiserum was verified by immunodiffusion, immunoelectrophoresis, and blocking experiments utilizing unlabeled antibody. Glomerular-bound IgG was eluted with acid citrate buffer, suggesting that IgG might be complexed with antigen(s) in glomerular deposits. By light microscopy, lesions ranged from focal proliferation and lobulation to more severe involvement with typical splitting of glomerular basement membranes, sclerosis, and less frequently, crescent formation. Ultrastructurally, all patients with classic MPGN exhibited mesangial and subendothelial deposits, and in 5 of these patients, subepithelial deposits were demonstrated. With the exception of ultrastructural lesions, patients with the dense deposit variant lacked distinguishable features when compared with those with classic MPGN. The significance of these findings is discussed in relation to a) activation of complement and the possible role of an immune complex mechanism and b) the variability of the morphologic expression.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 133617      PMCID: PMC2032448     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Dense deposit disease: a variant of membranoproliferative glomerulonephritis.

Authors:  R Habib; M C Gubler; C Loirat; H B Mäiz; M Levy
Journal:  Kidney Int       Date:  1975-04       Impact factor: 10.612

2.  The effect of anticomplementary substances on properdin in normal and C2-deficient sera.

Authors:  R H McLean; K Townsend; A F Michael
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

3.  Serum complement component levels in human glomerulonephritis.

Authors:  E J Lewis; C B Carpenter; P H Schur
Journal:  Ann Intern Med       Date:  1971-10       Impact factor: 25.391

4.  The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations.

Authors:  H Gewurz; R J Pickering; S E Mergenhagen; R A Good
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

5.  Chronic membranoproliferative glomerulonephritis with hypocomplementemia.

Authors:  A F Michael; R C Herdman; A J Fish; R J Pickering; R L Vernier
Journal:  Transplant Proc       Date:  1969-12       Impact factor: 1.066

Review 6.  Evidence for activation of the alternate pathway in glomerulonephritis.

Authors:  A F Michael; R H McLean
Journal:  Adv Nephrol Necker Hosp       Date:  1974

7.  Properdin levels in systemic lupus erythematosus and membranoproleferative glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  Clin Exp Immunol       Date:  1974-04       Impact factor: 4.330

8.  Morphology and serum complement levels in membranoproliferative glomerulonephritis.

Authors:  R Habib; C Loirat; M Gubler; M Levy
Journal:  Adv Nephrol Necker Hosp       Date:  1974

9.  Studies of serum complement in the hypocomplementaemic nephritides.

Authors:  D G Williams; D K Peters; J Fallows; A Petrie; O Kourilsky; L Morel-Maroger; J S Cameron
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

10.  Membranoproliferative glomerulonephritis and persistent hypocomplementaemia.

Authors:  J S Cameron; E F Glasgow; C S Ogg; R H White
Journal:  Br Med J       Date:  1970-10-03
View more
  19 in total

1.  Prolonged circulation of immune complexes due to various altered immune functions contributes to nephritis in MRL/lpr mice.

Authors:  N A Granholm; T Cavallo
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation.

Authors:  Valérie Leroy; Véronique Fremeaux-Bacchi; Michel Peuchmaur; Véronique Baudouin; Georges Deschênes; Marie-Alice Macher; Chantal Loirat
Journal:  Pediatr Nephrol       Date:  2010-12-25       Impact factor: 3.714

3.  Lipopolysaccharide from gram-negative bacteria enhances polyclonal B cell activation and exacerbates nephritis in MRL/lpr mice.

Authors:  T Cavallo; N A Granholm
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

4.  Ultrastructure in glomerulonephritis associated with cryoglobulinemia. A report of six cases and review of the literature.

Authors:  H Feiner; G Gallo
Journal:  Am J Pathol       Date:  1977-07       Impact factor: 4.307

5.  A case of membranoproliferative glomerulonephritis developed over twenty years with three different findings of renal pathology.

Authors:  Yoshikatsu Kaneko; Kazuhiro Yoshita; Hideyuki Kabasawa; Naofumi Imai; Yumi Ito; Mitsuhiro Ueno; Shinichi Nishi; Ichiei Narita
Journal:  CEN Case Rep       Date:  2012-11-09

6.  Modulation of mesangial cell migration by extracellular matrix components. Inhibition by heparinlike glycosaminoglycans.

Authors:  J M Person; D H Lovett; G J Raugi
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

7.  Bacterial lipopolysaccharide transforms mesangial into proliferative lupus nephritis without interfering with processing of pathogenic immune complexes in NZB/W mice.

Authors:  T Cavallo; N A Granholm
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

8.  Immunopathology of early and clinically silent lupus nephropathy.

Authors:  T Cavallo; W R Cameron; D Lapenas
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

9.  Murine lupus nephritis: effect of azathioprine on glomerular permeability and localization of immunoreactants.

Authors:  T Cavallo; K Graves; N A Granholm
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

10.  Immunopathology of the renal vascular lesion of progressive systemic sclerosis (scleroderma).

Authors:  D Lapenas; G P Rodnan; T Cavallo
Journal:  Am J Pathol       Date:  1978-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.